Answers are grounded in this paper and cite their sources.
We briefly introduce the most common lysosomal storage disorder, Gaucher disease, concisely describe the Food and Drug Administration approved strategies to ameliorate Gaucher disease, and then outline the emerging pharmacologic chaperone strategy that offers the promise to remedy this malady.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: